نتائج البحث - Steffen Falgreen

  • يعرض 1 - 4 نتائج من 4
تنقيح النتائج
  1. 1
    Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial

    Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The ons... حسب Bode, Bruce W., Iotova, Violeta, Kovarenko, Margarita, Laffel, Lori M., Rao, Paturi V., Deenadayalan, Srikanth, Ekelund, Magnus, Larsen, Steffen Falgreen, Danne, Thomas

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل احصل على النص الكامل
    نص
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The onset 7 Trial

    Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec, in Children and Adolescents With Type 1 Diabetes: The ons... حسب Bruce W. Bode, Violeta Iotova, М. А. Коваренко, Lori M. Laffel, Paturi Vishnupriya Rao, Srikanth Deenadayalan, Magnus Ekelund, Steffen Falgreen Larsen, Thomas Danne

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma

    High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma حسب Sara Correia Marques, Benyamin Ranjbar, Maria Bach Laursen, Steffen Falgreen, Anders Ellern Bilgrau, Julie Støve Bødker, Laura Krogh Jørgensen, Maria Nascimento Primo, Alexander Schmitz, Marianne Schmidt Ettrup, Hans Erik Johnsen, Martin Bøgsted, Jacob Giehm Mikkelsen, Karen Dybkær

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis

    Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes With Prognosis حسب Karen Dybkær, Martin Bøgsted, Steffen Falgreen, Julie Støve Bødker, Malene Krag Kjeldsen, Alexander Schmitz, Anders Ellern Bilgrau, Zijun Y. Xu‐Monette, Ling Li, Kim Steve Bergkvist, Maria Bach Laursen, María Rodrigo-Domingo, Sara Correia Marques, Sophie Bech Rasmussen, Mette Nyegaard, Michael Gaihede, Michael Møller, Richard J. Samworth, Rajen D. Shah, Preben Johansen, Tarec Christoffer El‐Galaly, Ken H. Young, Hans Erik Johnsen

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: